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Abstract Genetic e¡ects on behavioural measures thought to
model anxiety have been reported on 15 mouse chromosomes. In
general the individual e¡ect from each locus is small, contrib-
uting to 10% or less of the total variation, but through use of
crosses between inbred rodents the power to detect such e¡ects
is high: 39 loci have been reported at stringent levels of signi¢-
cance. Novel multivariate analyses of these data go some way to
characterizing the genetic architecture of anxiety and also to
validating the tests that are used for its measurement. However,
we are still some way from ¢nding the molecular variants that
explain the heritability of the trait. ) 2002 Published by El-
sevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Over half a century of quantitative genetic research, using
both animal and human subjects, leaves no room for doubt
that genetic di¡erences are an important factor in driving
individual variation in anxiety [1]. However, ¢nding the genet-
ic variants that are responsible has proved to be far more
di⁄cult than most people expected, primarily because the ge-
netic e¡ects have turned out to be smaller than anticipated,
and also, it is surmised, because they act in a more compli-
cated fashion than was appreciated. In the majority of cases,
since the phenotype is measured quantitatively, the genetic
loci are referred to as quantitative trait loci or QTL, a con-
vention I will adhere to in this review.
The problem of identifying small genetic e¡ects has come to
plague the analysis of almost all complex traits in humans,
including those of medical importance such as depression and
anxiety, but ¢nding the location of such e¡ects has not ham-
pered progress in animal studies, where the use of crosses
between inbred strains of mice simpli¢es the genetic analysis
considerably. Considering only studies that have mapped ge-
netic loci that in£uence behaviour, over the last seven years 45
publications have reported at least one statistically signi¢cant
result [1]. In total, well over 200 QTL have been reported. Of
these, at least 80 QTL are believed to in£uence one or more
animal measures of anxiety (Table 1). The problem for those
working with animals is not the detection of QTL, of which
there is an excess, but to progress from gene location to gene
[2].
My interest here is the genetic e¡ects that in£uence varia-
tion in behaviour in animal models of human susceptibility to
anxiety. Such models are not perfect. Indeed, some may be
criticized for having little or nothing to do with anxiety on the
grounds that the behavioural variation can be explained by
variation in levels of activity rather than emotion [3]. Most of
the anxiety models that can be applied to mice, the rodent
geneticists prefer, depend on measuring a change in an ani-
mal’s activity. For example, the commonly used elevated plus
maze looks for di¡erences in the number of entries an animal
makes into exposed, presumably threatening, sections of the
apparatus; a fast moving animal will tend to make more en-
tries than a slow moving one. Of course, it is possible to apply
corrections, such as the activity level in non-threatening envi-
ronments, but nevertheless problems of interpretation still sur-
round the use of the apparatus and others like it, which in-
clude the light^dark box and open-¢eld arena. Tests of
anxiety developed for work with rats, such as fear-potentiated
startle, are more robust to such criticism of validity [4,5], but
are more time consuming to carry out and may not be adapt-
able for use with mice. It should be noted that, because the
genetic e¡ects are small, a genetic mapping experiment re-
quires hundreds of mice [6]. A conditioned test, such as the
fear-potentiated startle, requires up to a week or more of
training. Therefore, achieving adequate sample sizes to detect
QTL for the more reliable measures of anxiety is demanding.
2. Genetic mapping of anxiety in rodents
Table 1 shows the published mapping results for measures
of anxiety in rodents and it is dominated by the simple, ac-
tivity-based tests. Only one report gives a result for using a
conditioned test, two-way active avoidance, in the rat. Never-
theless, whatever one’s view of the relevance of the phenotype,
it is clear that the genetic e¡ects discovered to date are many
and small. Fifteen of the mouse’s 19 chromosomes are impli-
cated in in£uencing behaviour in at least one test and some
chromosomal regions appear to in£uence almost a dozen dif-
ferent (but correlated) measures of anxiety. In the majority of
cases the probability that the investigators have found a QTL
is beyond reasonable doubt. A simple criterion for establish-
ing signi¢cance for studies of the kind reported here (an F2
intercross) is whether the LOD score exceeds 4.3: Table 1
shows 39 results that exceed this stringent threshold. And in
one case the results have been replicated [7].
The e¡ect sizes, expressed as a percentage of the variation
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Table 1
QTL that in£uence anxiety in rodents
Measure Species Strains Chr. Pos. LOD E¡ect Reference
Acoustic startle response Mouse NZB B/NJ 4 66 4.8 7.3 [26]
Mouse NZB B/NJ 4 51 3.9 10 [26]
Mouse NZB B/NJ 7 3 2.3 3.9 [26]
Rat RHA RLA 10 34 3.5 5.5 [13]
Rat RHA RLA 15 44 4.8 2.8 [13]
EPM % open arm entries Mouse DeFries High and Low 1 80 15.4 5.6 [12]
Mouse DeFries High and Low 4 46 3.2 1.2 [12]
Mouse A/J CBA/J 5 60 25 42 [8]
Mouse A/J CBA/J 5 60 12 51 [8]
Mouse DeFries High and Low 15 22 12.9 4.7 [12]
Mouse DeFries High and Low 18 22 7.9 2.9 [12]
Rat RHA RLA 5 80 4.1 2.6 [13]
Rat LEW SHR 6 2.8 6.5 [27]
EPM no. closed entries Mouse A/J CBA/J 7 Tyr 5 [8]
Mouse A/J CBA/J 7 Tyr 2.3 [8]
Rat LEW SHR 7 2.9 18.4 [27]
EPM no. open arm entries Mouse A/J CBA/J 5 60 28 41 [8]
Mouse A/J CBA/J 5 60 26 35 [8]
LD latency Mouse DeFries High and Low 1 80 6.8 2.5 [12]
Mouse DeFries High and Low 11 20 5.3 1.9 [12]
Mouse DeFries High and Low 14 20 8.7 3.1 [12]
Mouse DeFries High and Low 15 24 17.9 6.5 [12]
Mouse DeFries High and Low 18 34 6.5 2.3 [12]
LD transitions (3 days) Mouse A/J C57BL/6 1 67 2.5 2.5 [28]
Mouse A/J C57BL/6 6 10 2.9 3.5 [28]
Mouse A/J C57BL/6 10 74 9.5 8.4 [28]
Mouse A/J C57BL/6 15 42 2.5 2.5 [28]
Mouse A/J C57BL/6 19 21 4 3.9 [28]
LD transitions, Day 1 Mouse A/J C57BL/6 10 74 8.9 7.9 [28]
LD transitions, Day 2 Mouse A/J C57BL/6 19 21 2.5 2.5 [28]
Mirror chamber ^ latency Mouse DeFries High and Low 5 18 3.5 1.3 [12]
Mouse DeFries High and Low 12 60 3.2 1.2 [12]
Mouse DeFries High and Low 15 22 17.7 6.4 [12]
OF activity (5 min) Mouse DeFries High and Low 1 74 27.4 9.9 [12]
Mouse DeFries High and Low 4 36 3.5 1.3 [12]
Mouse DeFries High and Low 7 52 13 4.7 [12]
Mouse DeFries High and Low 12 40 3.6 1.3 [12]
Mouse DeFries High and Low 15 20 12.5 4.5 [12]
Mouse DeFries High and Low 18 32 5.4 2 [12]
Mouse DeFries High and Low X 14 5.3 1.9 [12]
Mouse A/J C57BL/6 1 100 7.1 6.3 [29]
Mouse A/J C57BL/6 10 74 8.8 8.3 [29]
Mouse A/J C57BL/6 15 42 3.6 3.6 [29]
Mouse A/J C57BL/6 19 24 3.2 3.2 [29]
Rat RHA RLA 3 0 5 2.6 [13]
Rat RHA RLA 5 88 3.1 1.9 [13]
OF activity (last ¢ve min of the
second 15-min trial)
Mouse A/J C57BL/6 1 69 3.1 4 [29]
Mouse A/J C57BL/6 3 44 4.1 8 [29]
Mouse A/J C57BL/6 10 74 14.7 12.7 [29]
Mouse A/J C57BL/6 19 24 3.6 4.1 [29]
OF activity in centre Rat LEW SHR 4 30 10.4 61.3 [27]
Rat LEW SHR 5 30 3.7 3.7 [27]
OF centre time (day 1, ¢rst 5 min) Mouse A/J C57BL/6 1 73 7.7 6.8 [28]
Mouse A/J C57BL/6 19 19 2.5 2.8 [28]
OF defecation Mouse DeFries High and Low 1 74 14.5 5.2 [12]
Mouse DeFries High and Low 14 20 9.4 3.4 [12]
Mouse DeFries High and Low X 50 5.4 1.9 [12]
Rat RHA RLA 3 8 3.2 2 [13]
Rat RHA RLA 6 50 3.4 8 [13]
Rat RHA RLA 19 56 3.3 3.2 [13]
Rat RHA RLA X 64 6.2 3.7 [13]
OF vertical movement, T1 Mouse A/J C57BL/6 1 79 4.5 5.9 [29]
Mouse A/J C57BL/6 10 74 8.5 7.6 [29]
Mouse A/J C57BL/6 19 24 3.8 4.2 [29]
OF vertical movement, T2 Mouse A/J C57BL/6 1 102 5.8 5.4 [29]
Mouse A/J C57BL/6 8 26 3.1 3 [29]
Mouse A/J C57BL/6 10 74 6.1 5.4 [29]
Mouse A/J C57BL/6 11 54 3.3 5 [29]
Mouse A/J C57BL/6 19 24 4.7 5 [29]
Two-way active avoidance Rat RHA RLA 5 76 9.5 5.7 [13]
Rat RHA RLA 10 22 4.1 3 [13]
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in the phenotype, are small ; almost all are less than 10% of
the total. The egregious exceptions are the studies by Ramos
et al. and the study by Cohen et al. The latter studied elevated
plus maze behaviour in a cross between CBA/J and A/J
strains [8]. The authors ¢nd a QTL that explains about half
the phenotypic variance on chromosome 5. However, this
study has probably identi¢ed a known Mendelian mutation,
which explains the large e¡ect size. It is reasonable to assume
that an animal’s visual acuity is likely to in£uence its behav-
iour in the elevated plus maze. The cross Cohen and col-
leagues used for QTL mapping included one strain, CBA/J,
that has a retinal degeneration mutation. The mutation is
recessive and lies on chromosome 5, within the QTL peak
reported by Cohen et al. [8]. While the data do not prove
that the mutation underlies the QTL, the evidence points in
that direction.
A QTL with an unusually large e¡ect size is also reported
by Ramos and colleagues [9]. In a cross between two rat
strains (LEW and SHR) they ¢nd a QTL on chromosome 4
that accounts for 61.3% of the variance of inner locomotion in
an open-¢eld arena. Two features of this ¢nding are odd.
First, the QTL analysis detects an allele in the LEW strain
that increases activity, yet the LEW strain actually has a lower
activity than the SHR strain. If the direction of e¡ect and
e¡ect size are correct, then there must be QTL alleles operat-
ing in the opposite direction whose total e¡ects exceed that of
the detected QTL. This is impossible if the single QTL e¡ect
size already explains more than half the total variance, unless,
in the inbred strain, there happens to be a particular confor-
mation of alleles that obscures the e¡ect. Second, they ¢nd
that the e¡ect is not just sex speci¢c but also depends on the
strain origin: LEW grandmother. The LOD score for the 48
female animals with a LEW grandmother is 7.2, but no other
strain combination exceeds a LOD of 2. This is incompatible
with the LOD score of 10.4 for all females (there must be an
e¡ect from the other animals to increase the LOD). These two
observations suggest we should treat this result with caution.
Overall, therefore, e¡ect sizes are small.
3. Genetic validation of emotionality
We can conclude that there is substantial evidence for the
presence of multiple QTL that in£uence behaviour in animal
models of anxiety. But it is possible to use genetic approaches
to go one step further and examine the validity of the animal
models, asking whether the genetic evidence supports the pre-
dictions of psychological theory [10]. We have tackled this
question in two separate experiments, using mice and rats,
to see if variation in susceptibility to anxiety, or emotionality
as it is often called in the rodent literature [11], is a unitary
construct.
We have mapped phenotypes believed to re£ect, in both
mice [7,12] and rats [13], di¡erent aspects of susceptibility to
anxiety, and asked to what extent the action of the QTL
matches the expectation that a single psychological process
underlies emotionality. In the mouse study we used ¢ve tests
of emotionality to phenotype over 1600 F2 animals. We found
that QTL on chromosomes 1, 4, 15 and 18 in£uenced at least
one measure obtained in all ¢ve tests, as would be expected if
they represented the genetic basis of emotionality [12].
We also mapped QTL in£uencing fearful behaviour in an
F2 cross of over 800 Roman High and Low avoidance rats
(RHA and RLA respectively). These rats are the product of
bi-directional selection for two-way active avoidance acquisi-
tion in a shuttle box [14], and the behavioural di¡erences of
the two strains are consistent with an inter-strain variation in
responses to fear stimuli. Again we used a large battery of
behavioural measures: measures of conditioned fear (both
contextual and cued), open-¢eld and elevated plus maze be-
haviours, acoustic startle response and spontaneous activity as
well as two-way active avoidance acquisition. We detected
three QTL chromosomes, 5, 10 and 15, that in£uenced more
than one behavioural measure of emotionality [13].
We had to decide whether any of the QTL acted on emo-
tionality in a manner consistent with what is known about the
psychological processes underlying anxiety. There were two
predictions that could be made: 1) the QTL should act con-
sistently across di¡erent tests of anxiety; 2) and an allele of
the QTL that has a supposedly anxiolytic e¡ect in one test
(for example, by increasing entries into the open arms of an
elevated plus maze) should act consistently in other tests (for
example, by increasing avoidance responses in the shuttle
box).
By categorizing QTL on the basis of the direction that each
allele works and their pattern of action across tests, we can
de¢ne how a QTL operates. In the mouse study a QTL on
chromosome 4 in£uences locomotor activity, not emotional-
ity: it acts on activity in the home cage (a non-threatening
environment) and has no e¡ect on the time spent in anxio-
genic regions of the elevated plus maze (the open arms). By
contrast, QTL on mouse chromosomes 1 and 15 did not in-
£uence spontaneous activity but did have e¡ects on time spent
in the open arms of the maze, in the light compartment of the
light^dark box and in the centre of the open ¢eld, all of which
are anxiogenic regions [15^18]. These QTL, on chromosomes
1 and 15, are thus candidates for loci that in£uence emotion-
ality.
In the rat mapping experiment multivariate analysis indi-
cated that three loci (on chromosomes 5, 10 and 15) had
broad e¡ects across di¡erent test measures. The QTL on chro-
mosome 5 matched the pattern of activity of a gene in£uenc-
ing an animal’s reaction to a fear stimulus, and parallels the
e¡ects of drugs used to treat anxiety disorders in humans
[19,20]. At this locus, on rat chromosome 5, the allele that
increased avoidances in the shuttle box also decreased cue and
contextual fear conditioning, while increasing time in the open
arms of the elevated plus maze and activity in the open ¢eld.
As I have explained above, QTL analysis has the power to
detect remarkably small e¡ects. I have now argued that it can
determine whether di¡erent phenotypes are under the control
6
Table 1. Measure: behavioural tests used to measure anxiety. OF, open-¢eld arena; EPM, elevated plus maze; LD, light^dark box. Strains:
the inbred strains used in the QTL mapping experiment. Chr. and Pos.: gives the position in centiMorgans for the QTL. Tyr: refers to the ty-
rosinase gene (c locus) on mouse chromosome seven. LOD: the likelihood measure of the presence of a QTL on the chromosome. E¡ect: per-
centage of the phenotypic variances explained by the QTL.
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of the same QTL and, at least at one level, establish that
susceptibility to anxiety (emotionality) is a unitary construct
as predicted by some theories of anxiety.
4. Gene identi¢cation
Successful genetic mapping is powerful because it is carried
out in inbred strains where genetic variation has been consid-
erably reduced: the e¡ects of any one locus are relatively
increased compared to their e¡ect in a more complex popu-
lation of animals where many other loci may be contributing
to the phenotype and there may even be multiple alleles at
each QTL. But the power to detect a small genetic e¡ect is
bought at the price of poor mapping resolution. For a QTL
explaining 4% of the phenotypic variance, the 95% con¢dence
interval will be about 40 centiMorgans when mapped in an F2
with 400 animals [21]. In other words, most of the studies
reported in Table 1 locate a QTL to within half a chromo-
some. We might reasonably ask if this is much of an advance
on earlier quantitative genetic studies that gave estimates of
the heritability of each phenotype. Genetic mapping has so far
done nothing to uncover the molecular basis of individual
variation in tests of anxiety.
There are two strategies which may accelerate ¢ne-mapping
and gene identi¢cation. The ¢rst is to start using outbred
animals for mapping. We have shown that the use of genet-
ically heterogeneous mice, derived from known inbred pro-
genitor strains and randomly intercrossed for more than 30
generations, can be used to map small e¡ect QTL to under a
centiMorgan [22]. We have also shown theoretically that a
cross between an inbred strain and heterogeneous mice can
be used both to screen the genome and to ¢ne-map QTL, so
that the burden of genotyping is reduced to a point where
most laboratories should be able to localize a QTL to within
a couple of centiMorgans [23].
The second strategy is to use quantitative complementation,
as pioneered in Drosophila [24]. The idea behind the quanti-
tative complementation test is that crosses between a strain
carrying a recessive mutation in the gene in£uenced by the
QTL and di¡erent inbred strains will uncover alleles that
have di¡erent quantitative e¡ects on the trait. A cross is set
up between a strain bearing a QTL that increases the pheno-
type (I) and a mutant. The phenotypes of the F1 progeny are
compared with the F1 o¡spring of I and the wildtype. An
analogous pair of crosses is established, replacing the I strain
with a strain bearing a di¡erent QTL allele, one that decreases
the phenotype. The QTL is detected by a test for an interac-
tion between mutant and strain, using an analysis of variance.
No one has yet carried out quantitative complementation in
mice, but John Schimenti has reported the use of deletions to
re¢ne the localization of QTL in£uencing sterility and segre-
gation distortion associated with mouse t haplotypes [25].
Progress in mapping and sequencing the mouse and human
genomes, the development of better methods of high resolu-
tion mapping, together with better functional tests of a QTL
(such as gene expression analysis) are opening the doors to
¢nding the molecular variants that govern variation in com-
plex traits such as anxiety. Fine-mapping experiments can
now uncover a series of candidate genes that might in£uence
a phenotype. The challenge over the next few years is to con-
¢rm those candidates and move into the next phase of the
molecular dissection of anxiety: functional characterization
of the genes involved.
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